| Dear Voornaam
Are you interested in receiving funding and guidance designed to help turn your innovative ideas into a cancer treatment, diagnostic or medical device? The Cancer Research Horizons £15m+ Seed Fund can help to bridge the funding gap.
By working with Cancer Research Horizons, our innovation engine, you’ll not only receive rapid access to validation of business concept, Pre-Seed and Seed Capital, the funding comes with access to commercial advice and guidance through our network of experts, mentors and management teams. We’ll also support you with introductions to co-investors to maximise the chances of your ideas becoming financially attractive to investors. |
|
|---|
|
|---|
|
|
Funding & Research Opportunities |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
|
|
NEW PROSTATE CANCER DATASET AVAILABLE A unique clinical imaging dataset from the Prostate MRI Imaging Study (PROMIS) is now available to researchers for non-commercial, non-profit use.
This dataset is offered by the National Cancer Imaging Translational Accelerator (NCITA) and the ReIMAGINE Consortium. It consists of over 500 MRI scans from patients across the UK and includes paired MRI scanning and mapped biopsy of the entire prostate.
With applications in developing machine learning tools or to inform further research, the dataset has potential to speed up prostate cancer diagnosis and treatment. |
|
|---|
|
|---|
|
|
 A REAL EUREKA MOMENT FOR TRANSLATION “We developed and practiced relevant skills, such as team building, thinking creatively, and working with different stakeholders,” describes Jacqui Marshall, Research Programme Manager at Cancer Research UK.
Jacqui reports back from the Eureka international course on translational medicine – an experiential learning opportunity for early career researchers in oncology.
Cancer Research Horizons is sponsoring places on two Eureka courses this year. Are you interested in learning more or an opportunity to develop your translational skills?
Read more about the summer course that took place in Sicily and how to apply to the programme.
|
|
|---|
|  BEATSON INSTITUTE TO HOST SCOTTISH DRUG DISCOVERY CONFERENCE We invite you to join us at the Beatson Institute for ELRIG UK's Scottish Research and Drug Development Forum. The event takes place on 27 April.
Neil Carragher (University of Edinburgh) will open the forum by taking us through the recent advances in high content imaging to profile drug mechanisms. Also, on the programme are the latest drug discovery approaches to traditional small molecules, therapeutic proteins, biologics and cells, vaccines, RNA and AI. |
|
|---|
|
|---|
|
|
RADIATION RESEARCH IN A GLOBAL CONTEXT 4–6 JUNE 2023 If you work or are interested in the field of radiation research, join us for stimulating conversations on the latest developments in radiotherapy drug combinations, AI and computational modelling, translational radiobiology and immunology.
Our new Radiation Research Conference, in collaboration with the Association for Radiation Research, brings together international experts to explore radiation research in a global context.
|
|
|---|
|
|---|
|
|
 SUBMIT YOUR RESEARCH OUTPUTS Are you a Cancer Research UK-funded researcher or PhD student? Our submission period to share your research outputs is now open. You can find FAQs and submission tips on our website.
The information you share is key to evaluating our shared progress and helping us communicate it to our supporters and partners. |
|
|---|
|  IS GLOBALISATION THE FUTURE OF CANCER RESEARCH? A question Robert Bristow, the Director of the Manchester Cancer Research Centre, explores in a recent Manchester Cancer Research podcast.
Sharing insights from his research into prostate cancer, Robert highlights the importance of considering ethnicity to improve cancer outcomes and tackle health inequalities.
Find out more about his vision of working closely with local and global communities and in international teams to start the next era of precision medicine.
|
|
|---|
|
|---|
|
|
DISCOVER WHO’S BEHIND THE SCIENCE The contributions of Dame Valerie Beral, Anne Szarewski, Nandita deSouza and Yvonne Barr to cancer research are improving the outcomes for people with cancer to this day.
From unpicking the risks of the contraceptive pill, influencing the decision to routinely test for HPV, trialling new imaging devices that provide high quality images from within the body to discovering the first virus that could cause cancer – these are only some of the achievements that these pioneering women are celebrated for.
Gender stereotypes, a lack of role models and male dominated cultures make it difficult for women in science. That’s why we put together a blog series to recognise some of the inspiring women working in oncology. |
|
|---|
|
|---|
|
|
| | | Online 5:00 PM 21 February 2023 |
|
|---|
|
|---|
| | | Online 10:30 AM 23 February 2023 |
|
|---|
|
|---|
| | | Online 12:00 PM 27 February 2023 |
|
|---|
|
|---|
| | | Glasgow, UK 27 April 2023 |
|
|---|
|
|---|
| | | Torino, Italy 12 June 2023 |
|
|---|
|
|---|
| | | London, UK 10 October 2023 |
|
|---|
|
|---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
|---|
|
|---|
|
|
| Been forwarded this email?
Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
